Ping An
China’s Ping An raises $2.2b for healthcare, fintech units
Ping An Insurance Group has raised $2.2 billion in private equity funding for its three technology businesses: Ping An Good Doctor, Ping An Healthcare Management, and OneConnect Financial Technology.
Advantech, SDIC lead $76m round for China biotech player
Advantech Capital and SDIC Fund Management have led a $76 million Series A round for Chinese biotechnology company KBP Biosciences.
Ping An Capital invests $121m in Singapore's Fullerton Healthcare
Ping An Capital, an investment unit of China’s Ping An Insurance, has invested more than RMB800 million ($121 million) in Fullerton Healthcare Corporation, which provides healthcare services to more than 25,000 corporations in Asia.
China genomics player Annoroad raises $105m Series C
Beijing-based genomics services provider Annoroad has completed a RMB700 million ($105 million) Series C round co-led by Shenzhen GTJA Investment Group and Ping An Ventures. SBCVC and SAIF Partners China also participated.
Ping An leads $75m round for YY's gaming subsidiary Huya
China Ping An Insurance has led a $75 million Series A round for Huya, the live game broadcasting subsidiary of Chinese social networking platform YY.
China's Ping An to launch $1b global fintech, healthcare fund
China’s Ping An Insurance is launching a $1 billion fund that will make financial technology and healthcare investments globally as the company looks to establish a footprint beyond its home market.
Ping An leads Series C for Singapore’s Bigo Live
Bigo Live, a Singapore-based social video streaming app, has raised a Series C round of funding from a Hong Kong-based investment arm of Ping An Insurance Group.
Australia's QIC announces partnership with Ping An
Australia’s QIC has reached an agreement with Ping An Asset Management (PAAMC), the asset management arm of Ping An Insurance, which will allow the Chinese group to tap into QIC’s experience in alternatives.
China's Innovent Biologics gets $260m Series D round
A fund controlled by China’s State Development & Investment Corporation (SDIC) has led a $260 million Series D round of funding for Innovent Biologics, a domestic biopharmaceutical company working on treatments for cancer, autoimmune disorders and heart...
Chinese LPs: Untapped potential
Still at an early stage of its development, China’s LP community has minimal exposure to offshore private equity. Institutions with big checkbooks aren’t necessarily the fastest movers
SBCVC-backed data center business files for US IPO
China-based data center provider GDS Holdings, in which SBCVC and Ping An Insurance are minority shareholders, has filed for a NASDAQ IPO.
Ping An commits $300m to PE-backed logistics platform
Ping An Real Estate, the real estate investment and asset management platform of China's Ping An Insurance Group, has committed $300 million to e-Shang Redwood (ESR), a real estate logistics platform backed by Warburg Pincus with operations in China,...
Healthcare app launched by China's Ping An Insurance raises $500m
Ping An Good Doctor, a healthcare-focused mobile app controlled by Chinese Ping An Insurance Group, has raised $500 million in a Series A round of funding at a valuation of $3 billion.
China TCM clinic chain Gu Sheng Tang raises $70m
Gu Sheng Tang, a traditional Chinese medicine (TCM) clinic chain, has raised $70 million in a Series C round led by US-based insurance firm Starr Companies, followed by China Ping An Insurance.
Chinese chemicals maker buys Tommee Tippee owner from 3i
Shanghai Jahwa United, a Chinese chemical products maker wholly owned by Ping An Insurance Group, has agreed to buy Mayborn Group – the UK-based manufacturer of Tommee Tippee baby bottles – from 3i Group.
UOB to launch Sino-Singapore fund in Chongqing
UOB Venture Management (UOBVM) will launch a Chongqing-based private equity fund of up to RMB100 billion ($15.4 billion) that will invest in companies addressing the China and Singapore markets.
Ping An leads $10m Series A for Hong Kong's Prenetics
Ping An Ventures, the VC arm of China's Ping An Insurance Group, has led a $10 million Series A round for Hong Kong-based genetic test developer Prenetics.
China fintech: Transition time
Capital continues to flow into China’s internet finance industry, but competition and regulation are changing the dynamics. VC investors can do well, provided they stay ahead of the game
China’s 58 Daojia merges with VC-backed beauty app
58 Daojia, a PE-backed Chinese online-to-offline (O2O) local services platform, has merged with Dudumeijia.com, a manicure-booking app that counts Sequoia Capital and Source Code Capital among its investors.
China’s Lufax raises $1.2b round
Shanghai Lujiazui International Financial Asset Exchange (Lufax), a Chinese online finance platform controlled by Ping An Insurance Group, has completed a $1.22 billion round of funding.
Rival bidder for China's iKang Healthcare hikes offer
A PE-backed consortium that includes Meinian Onehealth has increased its take-private offer for iKang Healthcare Group in response to a rival consortium led by the company’s founder bringing in a string of heavyweight investors.
Investors agree $9.3b take-private for China's Qihoo 360
A string of domestic insurance companies have come in to support the $9.3 billion buyout of Qihoo 360 Technology, the largest private equity-backed privatization of a US-listed Chinese company.
PE consortium completes take-private of China's WuXi PharmaTech
A consortium comprising the founder and CEO of WuXi PharmaTech and several PE investors has completed the privatization of the China-based provider of contract R&D services to global pharmaceutical companies.
Sequoia, Cathay join iKang take-private bid
Shenzhen-listed healthcare services provider Meinian Onehealth has teamed up with a group of investors – including Sequoia Capital and Cathay Capital Private Equity – to privatize its US-listed rival iKang Healthcare Group.